Saeed, Mohamed E. M.
Kadioglu, Onat
Greten, Henry Johannes
Yildirim, Adem
Mayr, Katharina
Wenz, Frederik
Giordano, Frank A.
Efferth, Thomas http://orcid.org/0000-0002-2637-1681
Funding for this research was provided by:
Johannes Gutenberg-Universität Mainz
Article History
Received: 24 September 2020
Accepted: 19 November 2020
First Online: 12 December 2020
Compliance with ethical standards
:
: The patient was enrolled in the INTRAGO trial [CitationRef removed], which was registered at clinictrials.gov, no. NCT02104882 (registration date: 03/26/2014) (ExternalRef removed). INTRAGO was approved by the local ethics committee (Medical Ethics Commission II of the Faculty of Mannheim, University of Heidelberg 2013-548S-MA) and the Federal Office of Radiation Protection (Z 5-2246/2-2013-063).
: Informed written consent had been given by the patient that the data are allowed to be scientifically used and published (dated: January 26, 2016).
: All authors declare there is no conflict of interest. However, patent application #EP18211231 “A method to determine agents for personalized use” is disclosed.